The Medtronic RESOLUTE US Clinical Trial

Exclusion Criteria

• •Within 7 days of implant platelet count \<100,000 cells/mm³ or \>700,000 cells/mm³; WBC count \<3,000 cells/mm³; serum creatinine level \>2.5 mg/dl
• •Acute MI within 72 hrs of the index procedure (QWMI or any elevation of CK-MB \> lab upper limit of normal)
• •Previous PCI of target vessel(s) within 9 months prior to the procedure
• •Planned PCI of any vessel within 30 days post-index procedure and/or planned PCI of target vessel(s) within 12 months post-index procedure
• •History of stroke or TIA within prior 6 months
• •Participating in investigational drug/device study that has not completed primary endpoint or interferes with study endpoints
• •Inability to comply with required trial antiplatelet regimen
• •Previous stent in target vessel unless it has been at least 9 months since stent placed and target lesion(s) is/are at least 15 mm from previous stent
• •Target vessel(s) has/have other lesions w/ \> 40% diameter stenosis
• •Unprotected left main coronary artery disease